爵士製藥 JAZZ 深 滬
已收盤 08-07 16:00:00 美东时间
256.56
-0.090
-0.04%
華盛通- 最 高258.38
- 今 開257.49
- 成交量 97.07万股
- 最 低 254.69
- 昨 收 256.65
- 總市值 166.54亿
- 52周最高 265.045
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 117.10
- 委 比 84.62%
- 總股本 6491.46万
- 歷史最高 265.045
- 量 比 0.89
- 振 幅 1.44%
- 歷史最低 31.87
- 每 手 1
- 風險率 41.55%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Pharma Mar Flags Planned Loss of Zepzelca Second-Line SCLC Indication
An update from Pharma Mar SA ( ($ES:PHM) ) is now available. Pharma Mar said it...
08-05 23:45
美股前瞻 | 美国7月小非农不及预期！史上最大解禁潮明日来袭，SpaceX将迎1140亿美元冲击；闪迪、西数盘后放榜
美国7月“小非农”不及预期！现货黄金应声冲上4200美元；史上最大解禁潮明日来袭！SpaceX将迎1140亿美元冲击；闪迪、西数盘后放榜，存储概念能否再起升势？>>
08-05 20:27
美股大行评级 | Palantir、Snap、爵士制药获多家大行上调目标价；潜在涨幅176.34%！巴克莱维持Snap(SNAP)"超配"评级，目标价从15美元上调至16美元
今日重点评级关注：巴克莱：维持Snap"超配"评级，目标价从15美元升至16美元；Canaccord Genuity：维持阿梅雷斯克"买入"评级，目标价从59美元升至62美元
08-05 11:45
Needham Maintains Buy on Jazz Pharmaceuticals, Raises Price Target to $292
Needham analyst Ami Fadia maintains Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy and raises the price target from $282 to $292.
08-04 19:10
Jazz Pharmaceuticals Raises FY2026 Sales Guidance from $4.250B-$4.500B to $4.600B-$4.750B vs $4.517B Est
Jazz Pharmaceuticals (NASDAQ:JAZZ) raises FY2026 sales outlook from $4.250 billion-$4.500 billion to $4.600 billion-$4.750 billion vs $4.517 billion estimate.
08-04 04:11
Werewolf Therapeutics Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Werewolf Therapeutics reported Q2 2026 results, including a $21M payment from asset transactions, enabling continued development of its INDUKINE and INDUCER platforms. Cash decreased to $22M, with collaboration revenue of $21M and net income of $3.7M. The company plans to update on strategic alternatives and clinical trials in H2 2026.
07-31 11:00
美股大行评级 | 伯恩斯坦上调Robinhood目标价从130美元升至160美元；纽约梅隆银行、Datadog、五三银行、旅行者财产险集团获多家机构上调评级
今日重点评级关注：Needham：维持Immuneering"买入"评级，目标价从11美元升至18美元；富瑞：维持塞德斯医疗"买入"评级，目标价从90美元升至100美元
07-21 11:36
Jazz Targets Lung Cancer Growth With New Lurbinectedin–Durvalumab Trial
Jazz Pharmaceuticals ($JAZZ) announced an update on their ongoing clinical stud...
07-21 00:31
美股大行评级 | 台积电、联合健康、美国合众银行获多家大行上调目标价；奈飞、直觉外科遭数十家大行下调目标价
今日重点评级关注：摩根大通：维持联合大陆航空"超配"评级，目标价从156美元升至203美元；摩根士丹利：维持联合大陆航空"超配"评级，目标价从185美元升至190美元
07-20 13:49
Canaccord Genuity Initiates Coverage On Jazz Pharmaceuticals with Buy Rating, Announces Price Target of $290
Canaccord Genuity analyst Gary Nachman initiates coverage on Jazz Pharmaceuticals (NASDAQ:JAZZ) with a Buy rating and announces Price Target of $290.
07-17 18:36
